synthetic drugs

Episode 50: Sicarios and Supply Side Economics with Stewart Scott

On this episode, we discuss how Mexico became a flashpoint of the war on drugs, broader trends in American foreign policy and drug policy, as well as the evolution of synthetic drugs as the main category of illicit narcotics. Our guest is Stewart Scott, a security analyst who for years penned one of the best annual assessments of Mexico’s evolving cartels for Stratfor and has since transitioned to Torchstone Global, a private security consulting firm. 

Scott has worked in the trenches of intelligence and security for 35 years and began his career in army reserve and National Guard intelligence before spending 10 years as a special agent with the U.S. Department of State’s Diplomatic Security Service. 

During the height of the drug war’s surge under Ronald Reagan and George H.W. Bush, Scott was assigned to protect a Colombian judge who had signed an arrest warrant for Pablo Escobar. In 1993 he traveled to Bogota to help the Colombian government investigate a car bombing at a school supply market.

You can follow Scott on Twitter @stick631 and learn more at torchstoneglobal.com

If you liked this episode, here are others you might enjoy:
Episode 11: Beyond Borders — How the U.S. Exports Dangerous Drug Policy
Episode 31: Supervised Consumption: Narcotica Breaks Down Safehouse Ruling with Av Gutman
Episode 34: “Inside the Bloody War on Drugs”

Follow Narcotica on FacebookTwitter and support us on Patreon. Your support is appreciated! We’re on Spotify, iTunes, YouTube, Stitcher and more. Tell your friends about us!

Producers: Christopher Moraff, Troy Farah, Zachary Siegel
Co-producer: Garrett Farah
Music: Glass Boy / Chandiliers
Intro voice: Jenny Schaye
Image: Pixabay // edit: Troy Farah

Episode 32: How Synthetic Drugs Conquered the Globe

On today’s show, co-host Zachary Siegel interviews Ben Westhoff about how he gained access to a clandestine lab in China, the prominent role that America’s War on Drugs has played in producing deadlier, more potent drugs that no user actually really wants, and finally, that in order to save the lives of people using drugs, the US must adopt innovative harm reduction strategies that have been tested around the world, like supervised injection sites and drug checking.